Published on JIPO (https://www.jipo.gov.jm)

Home > Printer-friendly

Patent On AIDS Medicine Denied In India

Submitted by Anonymous on Wed, 01/05/2011 - 15:08
In:
image/jpeg iconPatent drugs.jpg [3]
Indian Patent Office reject
A decision by the Indian Patent Office to reject a patent on an AIDS drug last week has drawn acclaim from civil society and Indian generic pharmaceutical industries.

The decision was not based on a controversial article of Indian law aimed at preventing patent extensions but rather on the grounds of non-inventiveness. Abbott Laboratories, meanwhile, presented Intellectual Property Watch with justification for its Indian patent request.
The HIV combination drug ritonavir/lopinavir was
Full Story: Patent On AIDS Medicine Denied In India [4]

Copyright©Jamaica Intellectual Property Office.2009 All Rights Reserved
Source URL (retrieved on 05/28/2025 - 15:18): https://www.jipo.gov.jm/node/1041

Links:
[1] https://www.jipo.gov.jm/taxonomy/term/1
[2] https://www.jipo.gov.jm/taxonomy/term/41
[3] https://www.jipo.gov.jm/sites/default/files/Patent%20drugs.jpg
[4] http://www.ip-watch.org/weblog/2011/01/04/patent-on-aids-medicine-denied-in-india-seen-as-unlocking-market/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+ip-watch+%28Intellectual+Property+Watch%29